202 related articles for article (PubMed ID: 32696316)
1. Lysine oxidase exposes a dependency on the thioredoxin antioxidant pathway in triple-negative breast cancer cells.
Chepikova OE; Malin D; Strekalova E; Lukasheva EV; Zamyatnin AA; Cryns VL
Breast Cancer Res Treat; 2020 Oct; 183(3):549-564. PubMed ID: 32696316
[TBL] [Abstract][Full Text] [Related]
2. Methionine restriction exposes a targetable redox vulnerability of triple-negative breast cancer cells by inducing thioredoxin reductase.
Malin D; Lee Y; Chepikova O; Strekalova E; Carlson A; Cryns VL
Breast Cancer Res Treat; 2021 Dec; 190(3):373-387. PubMed ID: 34553295
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic cooperation between auranofin, a thioredoxin reductase inhibitor and anti-PD-L1 antibody for treatment of triple-negative breast cancer.
Raninga PV; Lee AC; Sinha D; Shih YY; Mittal D; Makhale A; Bain AL; Nanayakarra D; Tonissen KF; Kalimutho M; Khanna KK
Int J Cancer; 2020 Jan; 146(1):123-136. PubMed ID: 31090219
[TBL] [Abstract][Full Text] [Related]
4. Irreversible inhibition of cytosolic thioredoxin reductase 1 as a mechanistic basis for anticancer therapy.
Stafford WC; Peng X; Olofsson MH; Zhang X; Luci DK; Lu L; Cheng Q; Trésaugues L; Dexheimer TS; Coussens NP; Augsten M; Ahlzén HM; Orwar O; Östman A; Stone-Elander S; Maloney DJ; Jadhav A; Simeonov A; Linder S; Arnér ESJ
Sci Transl Med; 2018 Feb; 10(428):. PubMed ID: 29444979
[TBL] [Abstract][Full Text] [Related]
5. Diterpenoid natural compound C4 (Crassin) exerts cytostatic effects on triple-negative breast cancer cells via a pathway involving reactive oxygen species.
Richards CE; Vellanki SH; Smith YE; Hopkins AM
Cell Oncol (Dordr); 2018 Feb; 41(1):35-46. PubMed ID: 29134467
[TBL] [Abstract][Full Text] [Related]
6. Enhanced thioredoxin, glutathione and Nrf2 antioxidant systems by safflower extract and aceglutamide attenuate cerebral ischaemia/reperfusion injury.
Zhang J; Zhou R; Xiang C; Fan F; Gao J; Zhang Y; Tang S; Xu H; Yang H
J Cell Mol Med; 2020 May; 24(9):4967-4980. PubMed ID: 32266795
[TBL] [Abstract][Full Text] [Related]
7. Targeting of the Glutathione, Thioredoxin, and Nrf2 Antioxidant Systems in Head and Neck Cancer.
Roh JL; Jang H; Kim EH; Shin D
Antioxid Redox Signal; 2017 Jul; 27(2):106-114. PubMed ID: 27733046
[TBL] [Abstract][Full Text] [Related]
8. Effects of Mammalian Thioredoxin Reductase Inhibitors.
Arnér ESJ
Handb Exp Pharmacol; 2021; 264():289-309. PubMed ID: 32767140
[TBL] [Abstract][Full Text] [Related]
9. Methionine Deprivation Induces a Targetable Vulnerability in Triple-Negative Breast Cancer Cells by Enhancing TRAIL Receptor-2 Expression.
Strekalova E; Malin D; Good DM; Cryns VL
Clin Cancer Res; 2015 Jun; 21(12):2780-91. PubMed ID: 25724522
[TBL] [Abstract][Full Text] [Related]
10. Quercetin protects human granulosa cells against oxidative stress via thioredoxin system.
Rashidi Z; Aleyasin A; Eslami M; Nekoonam S; Zendedel A; Bahramrezaie M; Amidi F
Reprod Biol; 2019 Sep; 19(3):245-254. PubMed ID: 31383475
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of Thioredoxin/Thioredoxin Reductase Induces Synthetic Lethality in Lung Cancers with Compromised Glutathione Homeostasis.
Yan X; Zhang X; Wang L; Zhang R; Pu X; Wu S; Li L; Tong P; Wang J; Meng QH; Jensen VB; Girard L; Minna JD; Roth JA; Swisher SG; Heymach JV; Fang B
Cancer Res; 2019 Jan; 79(1):125-132. PubMed ID: 30401714
[TBL] [Abstract][Full Text] [Related]
12. Targeting Breast Cancer Stem Cell State Equilibrium through Modulation of Redox Signaling.
Luo M; Shang L; Brooks MD; Jiagge E; Zhu Y; Buschhaus JM; Conley S; Fath MA; Davis A; Gheordunescu E; Wang Y; Harouaka R; Lozier A; Triner D; McDermott S; Merajver SD; Luker GD; Spitz DR; Wicha MS
Cell Metab; 2018 Jul; 28(1):69-86.e6. PubMed ID: 29972798
[TBL] [Abstract][Full Text] [Related]
13. Estradiol regulates the thioredoxin antioxidant system in the mouse uterus.
Deroo BJ; Hewitt SC; Peddada SD; Korach KS
Endocrinology; 2004 Dec; 145(12):5485-92. PubMed ID: 15345672
[TBL] [Abstract][Full Text] [Related]
14. Reversing ROS-mediated neurotoxicity by chlorogenic acid involves its direct antioxidant activity and activation of Nrf2-ARE signaling pathway.
Yao J; Peng S; Xu J; Fang J
Biofactors; 2019 Jul; 45(4):616-626. PubMed ID: 30951611
[TBL] [Abstract][Full Text] [Related]
15. Activation of the Nrf2-regulated antioxidant cell response inhibits HEMA-induced oxidative stress and supports cell viability.
Gallorini M; Petzel C; Bolay C; Hiller KA; Cataldi A; Buchalla W; Krifka S; Schweikl H
Biomaterials; 2015 Jul; 56():114-28. PubMed ID: 25934285
[TBL] [Abstract][Full Text] [Related]
16. Benzophenanthridine Alkaloid Chelerythrine Elicits Necroptosis of Gastric Cancer Cells via Selective Conjugation at the Redox Hyperreactive C-Terminal Sec
Liu M; Sun S; Meng Y; Wang L; Liu H; Shi W; Zhang Q; Xu W; Sun B; Xu J
Molecules; 2023 Sep; 28(19):. PubMed ID: 37836684
[TBL] [Abstract][Full Text] [Related]
17. Targeting redox homeostasis in rhabdomyosarcoma cells: GSH-depleting agents enhance auranofin-induced cell death.
Habermann KJ; Grünewald L; van Wijk S; Fulda S
Cell Death Dis; 2017 Oct; 8(10):e3067. PubMed ID: 28981107
[TBL] [Abstract][Full Text] [Related]
18. Targeting Thioredoxin System with an Organosulfur Compound, Diallyl Trisulfide (DATS), Attenuates Progression and Metastasis of Triple-Negative Breast Cancer (TNBC).
Liu Y; Zhao Y; Wei Z; Tao L; Sheng X; Wang S; Chen J; Ruan J; Liu Z; Cao Y; Shan Y; Wang A; Chen W; Lu Y
Cell Physiol Biochem; 2018; 50(5):1945-1963. PubMed ID: 30396169
[TBL] [Abstract][Full Text] [Related]
19. Auranofin/Vitamin C: A Novel Drug Combination Targeting Triple-Negative Breast Cancer.
Hatem E; Azzi S; El Banna N; He T; Heneman-Masurel A; Vernis L; Baïlle D; Masson V; Dingli F; Loew D; Azzarone B; Eid P; Baldacci G; Huang ME
J Natl Cancer Inst; 2019 Jun; 111(6):597-608. PubMed ID: 30779852
[TBL] [Abstract][Full Text] [Related]
20. Alantolactone promotes ER stress-mediated apoptosis by inhibition of TrxR1 in triple-negative breast cancer cell lines and in a mouse model.
Yin C; Dai X; Huang X; Zhu W; Chen X; Zhou Q; Wang C; Zhao C; Zou P; Liang G; Rajamanickam V; Wang O; Zhang X; Cui R
J Cell Mol Med; 2019 Mar; 23(3):2194-2206. PubMed ID: 30609207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
